Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting
DESIGN: Retrospective cross-sectional multivariate logistic regression analyses of patients receiving QFT-G from October 2006 to June 2008. Analyses were performed separately depending on whether the indeterminate result was due to positive (low mitogen) or negative (high nil) control failure.
RESULTS: Of 28 864 individuals tested, 2058 (7%) tested positive, 26 284 (91%) negative, and 522 (2%) were indeterminate (low mitogen, n = 264; high nil, n = 258). Low mitogen results were more frequent among those aged < 10 years (ORadj 3.7, 95%CI 2.4–5.9), females (ORadj 1.4, 95%CI 1.1–1.8), Asians (ORadj 2.1, 95%CI 1.3–3.4) and the US-born (ORadj 1.9, 95%CI 1.4–2.6) and less frequent among Hispanics (ORadj 0.6, 95%CI 0.4–1.0). High nil results were more frequent among Hispanics (ORadj 1.7, 95%CI 1.0–2.8) and less frequent among the US-born (ORadj 0.6, 95%CI 0.5– 0.8). Among patients who received a repeat QFT-G (n = 137), 4% tested positive, 64% negative and 32% had a second indeterminate result, always of the same type.
CONCLUSION: Age, race/ethnicity and sex were associ- ated with indeterminate QFT-G results. Most follow-up tests were negative, although a modest proportion were repeatedly indeterminate. Further studies evaluating the mechanisms of QFT-G indeterminate results are needed.
Keywords: INTERFERON-GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS INFECTION; MYCOBACTERIUM TUBERCULOSIS; QUANTIFERON©-TB GOLD; TUBERCULOSIS
Document Type: Research Article
Affiliations: 1: Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA; New York City Department of Health and Mental Hygiene, New York, New York, USA 2: New York City Department of Health and Mental Hygiene, New York, New York, USA
Publication date: 01 December 2011
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content